A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Analgesic Efficacy Trial of Oral ARRY-371797 in Subjects Undergoing Third Molar Extraction
Latest Information Update: 10 Feb 2021
At a glance
- Drugs Emprumapimod (Primary) ; Celecoxib
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Array BioPharma; Pfizer
- 27 Oct 2008 Positive results data reported in a media release from Arry Biopharma.
- 22 Jun 2008 Status changed from recruiting to completed.
- 18 Apr 2008 The expected completion date for this trial is now 1 Aug 2008 according to ClinicalTrials.gov.